U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241065) titled 'A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants' on Nov. 17.
Brief Summary: The purpose of this study is to assess the effect of capivasertib on the pharmacokinetics of oral dextromethorphan in healthy participants.
Study Start Date: Jan. 28, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Dextromethorphan
Dextromethorphan will be administered orally once in Period 1 and once in Period 2
DRUG: Capivasertib
Capivasertib will be administered orally twice in Period 2
Recruitment Status: NOT_YET_REC...